Year
2013
Status
Exited
Team
Field
Immuno-oncology therapeutic
Location
Oss (The Netherlands)
Fund
BGV II
Acerta Pharma
Acerta Pharma develops novel therapeutics in oncology and autoimmune diseases. In 2016 AstraZeneca acquired a majority stake in Acerta Pharma.